Erratum: CCAAT/enhancer-binding protein d facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner (Proceedings of the National Academy of Sciences of the United States of America (2012) 109, 23, (9113-9118) DOI: 10.1073/pnas.1202641109);CCAAT/enhancer-binding protein δ facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 23, 2012, Pages 9113-9118

  Duitman, JanWillem ^a   Schouten, Marcel ^a   Groot, Angelique P ^a   Daalhuisen, Joost B ^a   Florquin, Sandrine ^a   Van Der Poll, Tom ^a   Spek, C Arnold ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Lung barrier; Tanscytosis

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; LIPOTEICHOIC ACID; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

BACTERIA (MICROORGANISMS); MUS; POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 84861882163     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1315309110     Document Type: Erratum

References (33)

1. Lekstrom-Himes J, Xanthopoulos KG (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273:28545-28548. (Pubitemid 28507532)
2. Alam T, An MR, Papaconstantinou J (1992) Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J Biol Chem 267: 5021-5024.
3. Juan TS, Wilson DR, Wilde MD, Darlington GJ (1993) Participation of the transcription factor C/EBP δ in the acute-phase regulation of the human gene for complement component C3. Proc Natl Acad Sci USA 90:2584-2588. (Pubitemid 23113460)
4. Hu HM, et al. (2000) The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J Biol Chem 275:16373-16381.
5. Beck GC, et al. (2006) Heterogeneity in lipopolysaccharide responsiveness of endothelial cells identified by gene expression profiling: Role of transcription factors. Clin Exp Immunol 143:523-533.
6. Wang JM, Ko CY, Chen LC, Wang WL, Chang WC (2006) Functional role of NF-IL6β and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene. Nucleic Acids Res 34:217-231.
7. Litvak V, et al. (2009) Function of C/EBPδ in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol 10:437-443.
8. Slofstra SH, et al. (2007) Gene expression profiling identifies C/EBPδ as a candidate regulator of endotoxin-induced disseminated intravascular coagulation. Am J Respir Crit Care Med 176:602-609. (Pubitemid 47403278)
9. Mandell LA, et al.; Infectious Diseases Society of America; American Thoracic Society (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27-S72. (Pubitemid 46290553)
10. Bernard GR, et al.; Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709. (Pubitemid 32204987)
11. Bartlett JG, et al.; Infectious Diseases Society of America (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31: 347-382. (Pubitemid 32289567)
12. Feldman C (2004) Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med 143:269-283.
13. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI (1995) Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377:435-438.
14. Radin JN, et al. (2005) β-Arrestin 1 participates in platelet-activating factor receptor- mediated endocytosis of Streptococcus pneumoniae. Infect Immun 73:7827-7835. (Pubitemid 41740265)
15. Rijneveld AW, et al. (2004) Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis 189:711-716. (Pubitemid 38270926)
16. Knapp S, Schultz MJ, van der Poll T (2005) Pneumonia models and innate immunity to respiratory bacterial pathogens. Shock 24(Suppl 1):12-18.
17. Lim JH, et al. (2007) Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 27:349-360. (Pubitemid 47284927)
18. Fu P, et al. (2009) Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. Eur Respir J 33:612-624.
19. Xia C, Cheshire JK, Patel H, Woo P (1997) Cross-talk between transcription factors NF- κB and C/EBP in the transcriptional regulation of genes. Int J Biochem Cell Biol 29: 1525-1539. (Pubitemid 28153502)
20. Gillespie SH, Ainscough S, Dickens A, Lewin J (1996) Phosphorylcholine- containing antigens in bacteria from the mouth and respiratory tract. J Med Microbiol 44:35-40. (Pubitemid 26048708)
21. van Zoelen MAD, et al. (2008) Platelet-activating factor receptor contributes to host defense against Pseudomonas aeruginosa pneumonia but is not essential for the accompanying inflammatory and procoagulant response. J Immunol 180:3357-3365.
22. Dagenais P, Thivierge M, Stankova J, Rola-Pleszczynski M (1997) Modulation of platelet-activating factor receptor (PAFR) gene expression via NFκB in MonoMac-1 cells. Inflamm Res 46(Suppl 2):S161-S162. (Pubitemid 27399611)
23. Knapp S, et al. (2008) Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J Immunol 180:3478-3484.
24. Bergeron Y, et al. (1998) Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun 66:912-922. (Pubitemid 28101126)
25. Giebelen IA, Leendertse M, Florquin S, van der Poll T (2009) Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia. Eur Respir J 33:375-381.
26. Keely S, et al. (2010) Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epithelia. Mol Biol Cell 21:538-546.
27. Garcia CC, et al. (2010) Platelet-activating factor receptor plays a role in lung injury and death caused by influenza A in mice. PLoS Pathog 6:e1001171.
28. Melnikova V, Bar-Eli M (2007) Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor. Cancer Metastasis Rev 26: 359-371. (Pubitemid 350115121)
29. Souza DG, et al. (2009) Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection. Proc Natl Acad Sci USA 106:14138-14143.
30. Sterneck E, et al. (1998) Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein δ. Proc Natl Acad Sci USA 95:10908-10913. (Pubitemid 28413167)
31. Rijneveld AW, et al. (2002) Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol 168:3507-3511. (Pubitemid 34250418)
32. Queiroz KC, et al. (2010) Hedgehog signaling maintains chemoresistance in myeloid leukemic cells. Oncogene 29:6314-6322.
33. Lukashova V, Chen ZG, Duhé RJ, Rola-Pleszczynski M, Stanková J (2003) Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): Roles of Tyk2 and PAFR C terminus. J Immunol 171:3794-3800. (Pubitemid 37254585)